'); } else { var query = elem.find('.keywords').html(); $.ajax({ context: elem, url: 'https://wn.com/api/upge/cheetah-search-adv/video', cache: true, data: { 'query': query }, dataType: 'jsonp', success: function(text) { if (text.length > 0) { video_id = text[0].id; elem.find('.player').html(''); } } }); } } var stopAllYouTubeVideos = function() { var iframes = document.querySelectorAll('iframe'); Array.prototype.forEach.call(iframes, function(iframe) { iframe.contentWindow.postMessage(JSON.stringify({ event: 'command', func: 'pauseVideo' }), '*'); }); } jQuery(function() { jQuery(".playVideo").live("click", function() { if(!$(this).hasClass("played")){ stopAllYouTubeVideos(); var elem = $(this); setTimeout(function(){ mouseOverMe(elem); }, 1000); } }); jQuery(".description_box .expandContent").live("click", function() { elem = $(this).parent().parent().parent().find('.descContent'); if(elem.height() > 51) { elem.css('height', '44px'); $(this).html('Show More '); }else{ elem.css('height', 'auto'); $(this).html('Hide '); } }); jQuery('.interview-play-off').click(function() { $(".interview-play-off").hide(); $(".interview-play").show(); $(".videoplayer-control-pause").click(); }); jQuery(".video-desc .show_author_videos").live("click", function() { query = $(this).attr('title'); container = $(this).parent().parent().parent().find('.video-author-thumbs'); $(this).parent().parent().parent().find('.video-author-thumbs').css('height', '220px'); jQuery.ajax({ url: '/api/upge/cheetah-photo-search/videoresults', data: {'query': query}, success: function(text) { if(!text) { text = i18n("No results"); } container.html(jQuery(text)); } }); }); }); // -->

Latest News for: gsk

Edit

Transaction in own shares (Form 6-K) (GSK plc)

Public Technologies 02 Apr 2026
GSK plc published this content on April 02, 2026, and is solely responsible ...
Edit

Samsung Biologics acquires GSK's U.S. facility for US$280 mln

Yonhap News 01 Apr 2026
SEOUL, April 1 (Yonhap) -- Samsung Biologics, the biotech arm of Samsung Group, ....
Edit

Total Voting Rights (Form 6-K) (GSK plc)

Public Technologies 01 Apr 2026
GSK plc ... In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GSK plc (the 'Company') hereby notifies the market of the following. ... Notifications may be sent to company.secretary@gsk.com ... About GSK.
Edit

Transaction notification (Form 6-K) (GSK plc)

Public Technologies 01 Apr 2026
GSK plc ... GSK plc (the 'Company') ... GSK plc ... Acquisition of ADS under GSK pension plan ... GSK plc ... Acquisition of ADS under GSK pension plan ... About GSK ... Find out more at www.gsk.com ... GSK plc ... behalf of GSK plc.
Edit

GSK, Pfizer and Shionogi complete changes to ViiV Healthcare shareholding (Form 6-K) (GSK plc)

Public Technologies 01 Apr 2026
GSK plc ... GSK, Pfizer and Shionogi complete changes to ViiV Healthcare shareholding ... ● Increase of Shionogi's holding to 21.7%, with GSK maintaining 78.3% majority share. GSK plc (LSE/NYSE. GSK) ("GSK"), and Shionogi & Co., Ltd (Head Office.
Edit

Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland

PR Newswire 31 Mar 2026
Samsung Biologics will continue supplying the products previously manufactured at the site to GSK under the terms of the agreement, and the site will transition to serve additional contract manufacturing needs.
Edit

Bepirovirsen accepted for regulatory review in China as a potential first-in-class functional cure for chronic hepatitis B (Form 6-K) (GSK plc)

Public Technologies 30 Mar 2026
GSK plc ... GSK plc (LSE/NYSE ... GSK licensed bepirovirsen from Ionis Pharmaceuticals and collaborated with them on its development ... About GSK ... Find out more at www.gsk.com. GSK enquiries ... GSK plc ... behalf of GSK plc.
Edit

Exdensur (depemokimab) approved in China for the treatment of severe asthma (Form 6-K) (GSK plc)

Public Technologies 30 Mar 2026
GSK plc ... GSK plc (LSE/NYSE ... Kaivan Khavandi, SVP, Global Head, Respiratory, Immunology & Inflammation R&D, GSK, said ... About GSK in respiratory ... About GSK ... Find out more at www.gsk.com. GSK enquiries ... GSK plc ... behalf of GSK plc.
Edit

GSK gets $9M state redevelopment grant for Lancaster County facility

Lancaster Online 27 Mar 2026
GSK’s planned investment of up to $800 million in its campus near Marietta got a $9 million boost from a state Redevelopment Capital Assistance Program grant earlier this year ... .
Edit

GSK plc Publication of Notice of Annual General Meeting 2026 (Form 6-K) (GSK plc)

Public Technologies 25 Mar 2026
GSK plc ... GSK plc Publication of Notice of Annual General Meeting 2026 ... About GSK. GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.com ... GSK plc.
Edit

Current Report by Foreign Issuer (Form 6-K) (GSK plc)

Public Technologies 25 Mar 2026
GSK plc published this content on March 25, 2026, and is solely responsible ...
Edit

GSK Proxy Form 2026 (GSK plc)

Public Technologies 25 Mar 2026
The GSK plc 2025 Annual Report and 2026 Notice of Annual General Meeting are now available to view and/or download in the Investors section of https.//www.gsk.com ... I/We, the undersigned, being a member/members of GSK plc, appoint the following person.
Edit

GSK Notice of AGM 2026 (GSK plc)

Public Technologies 25 Mar 2026
GSK plc ... I am pleased to enclose the Notice of Meeting for the twenty-sixth Annual General Meeting (AGM) of GSK plc (the company) ... Luke joined GSK in 2017 as Chief Commercial Officer responsible for our commercial portfolio of medicines and vaccines.
Edit

Articles of Association - Proposed Amendments (GSK plc)

Public Technologies 25 Mar 2026
). Company No. 3888792 ARTICLES OF ASSOCIATION ... OF. GSK plc. Company No. 3888792 ARTICLES OF ASSOCIATION ... OF. GSK plc. CONTENTS. Page ... 1 ... of GSK plc ... GSK plc published this content on March 25, 2026, and is solely responsible for the information contained herein.
×